These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, Marcos-Gragera R, Maynadié M, Monnereau A, Osca-Gelis G, Visser O, De Angelis R, EUROCARE-5 Working Group. Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467 [Abstract] [Full Text] [Related]
7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L. Epidemiol Prev; 2016 Aug; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [Abstract] [Full Text] [Related]
8. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study. De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, Visser O, Maynadié M, Marcos-Gragera R, Troussard X, Agius D, Roazzi P, Meneghini E, Monnereau A, EUROCARE-5 Working Group:. Eur J Cancer; 2015 Oct; 51(15):2254-2268. PubMed ID: 26421827 [Abstract] [Full Text] [Related]
9. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends. Howlader N, Morton LM, Feuer EJ, Besson C, Engels EA. Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423 [Abstract] [Full Text] [Related]
10. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report]. Zona A, Fazzo L, Benedetti M, Bruno C, Vecchi S, Pasetto R, Minichilli F, De Santis M, Nannavecchia AM, Di Fonzo D, Contiero P, Ricci P, Bisceglia L, Manno V, Minelli G, Santoro M, Gorini F, Ancona C, Scondotto S, Soggiu ME, Scaini F, Beccaloni E, Marsili D, Villa MF, Maifredi G, Magoni M, Iavarone I, Gruppo di lavoro SENTIERI 2019-2022. Epidemiol Prev; 2023 Jan; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373 [Abstract] [Full Text] [Related]
11. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features. Rasmussen PK. Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159 [Abstract] [Full Text] [Related]
12. Trends in net survival from colon cancer in six European Latin countries: results from the SUDCAN population-based study. Faivre J, Bossard N, Jooste V, GRELL EUROCARE-5 Working Group. Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S40-S47. PubMed ID: 28005604 [Abstract] [Full Text] [Related]
13. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I, EUROCARE-4 Working Group. Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993 [Abstract] [Full Text] [Related]
14. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5. Trama A, Botta L, Foschi R, Ferrari A, Stiller C, Desandes E, Maule MM, Merletti F, Gatta G, EUROCARE-5 Working Group. Lancet Oncol; 2016 Jul; 17(7):896-906. PubMed ID: 27237614 [Abstract] [Full Text] [Related]
15. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis? Minicozzi P, Walsh PM, Sánchez MJ, Trama A, Innos K, Marcos-Gragera R, Dimitrova N, Botta L, Johannesen TB, Rossi S, Sant M, EUROCARE-5 Working Group. Eur J Cancer; 2018 Apr; 93():127-137. PubMed ID: 29518726 [Abstract] [Full Text] [Related]
16. Trends in net survival from stomach cancer in six European Latin countries: results from the SUDCAN population-based study. Glória L, Bossard N, Bouvier AM, Mayer-da-Silva A, Faivre J, Miranda A, GRELL EUROCARE-5 Working Group. Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S32-S39. PubMed ID: 28005603 [Abstract] [Full Text] [Related]
17. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL, Figgitt DP. Drugs; 2003 Jan; 63(8):803-43. PubMed ID: 12662126 [Abstract] [Full Text] [Related]
18. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial. Locke FL, Ghobadi A, Jacobson CA, Miklos DB, Lekakis LJ, Oluwole OO, Lin Y, Braunschweig I, Hill BT, Timmerman JM, Deol A, Reagan PM, Stiff P, Flinn IW, Farooq U, Goy A, McSweeney PA, Munoz J, Siddiqi T, Chavez JC, Herrera AF, Bartlett NL, Wiezorek JS, Navale L, Xue A, Jiang Y, Bot A, Rossi JM, Kim JJ, Go WY, Neelapu SS. Lancet Oncol; 2019 Jan; 20(1):31-42. PubMed ID: 30518502 [Abstract] [Full Text] [Related]
19. Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France. Monnereau A, Troussard X, Belot A, Guizard AV, Woronoff AS, Bara S, Lapôtre-Ledoux B, Iwaz J, Tretarre B, Maynadié M, French Network of Cancer Registries (FRANCIM). Int J Cancer; 2013 May 15; 132(10):2378-87. PubMed ID: 23034773 [Abstract] [Full Text] [Related]
20. Italian cancer figures, report 2013: Multiple tumours. AIRTUM Working GroupAIRTUM Working Group: tumori.infantili@registri-tumori.it.. Epidemiol Prev; 2013 May 15; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]